|
Jul 25
|
U.S. Diagnostics Market Review 2020-2024 and Outlook to 2030 - Technological Advancements Lower Costs of Molecular Diagnostics, Reshape U.S. Healthcare Landscape
|
|
Jul 24
|
Europe’s Pharma Stocks Look Cheap but Tariffs Cloud the Outlook
|
|
Jul 24
|
Roche Weighs Selling Drugs Directly to Patients in Bid to Lower U.S. Prices
|
|
Jul 24
|
Roche Reports 7% 1H25 Sales Growth, Key Drugs Perform Well
|
|
Jul 24
|
Selective Estrogen Receptor Degrader (SERDs) Market Research Report 2025-2030 Featuring AstraZeneca, Eli Lilly, EnhancedBio, Olema Oncology, Radius Therapeutics, and Roche
|
|
Jul 24
|
Roche Diagnostics showcases science-driven leadership and innovation at ADLM 2025
|
|
Jul 24
|
Behcet's Disease Market Research Report 2025-2035 | Key Trends, Regulatory Framework, Epidemiology, Clinical Trial Analysis, Market Dynamics
|
|
Jul 24
|
Diffuse Large B-cell Lymphoma Market Research Report 2025-2035 | Personalized Medicine and Precision Treatment Trends in DLBCL
|
|
Jul 24
|
Pharma giant Roche sees income soar in first half
|
|
Jul 24
|
Roche boss says ‘very easy’ to cut US drug prices by 50%
|
|
Jul 24
|
[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum with 7% growth (CER) in the first half of 2025
|
|
Jul 23
|
Clinical Next Generation Sequencing Market Trends and Forecasts Report 2025-2032 | Personalized Medicine and R&D Investments Propel Growth
|
|
Jul 23
|
Will Keytruda Continue to Aid MRK's Top Line Ahead of Q2 Earnings?
|
|
Jul 23
|
Abivax Hits The Stratosphere, Up 500%, On 'Potentially Disruptive' Results
|
|
Jul 23
|
Roche’s Elecsys pTau181 test gains CE Mark to rule out Alzheimer’s
|
|
Jul 23
|
Cancer Diagnostics Market Outlook, Forecast Trends and Growth Report 2025-2034 | Increasing Fundings and Investments, Advanced Liquid Biopsy Technologies and Early Detection Methods Fuelling Growth
|
|
Jul 23
|
Roche receives CE Mark for minimally invasive blood test to help rule out Alzheimer’s disease
|
|
Jul 23
|
European Commission approves Roche’s Itovebi for people with ER-positive, HER2-negative, advanced breast cancer with a PIK3CA mutation
|
|
Jul 22
|
Roche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)
|
|
Jul 22
|
SRPT Slides on Voluntary US Elevidys Shipment Pause Amid Scrutiny
|